Abbott Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Abbott Laboratories
ABT Stock  USD 127.64  0.93  0.73%   
Abbott Laboratories financial statements provide useful quarterly and yearly information to potential Abbott Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Abbott Laboratories financial statements helps investors assess Abbott Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Gross Profit
23.3 B
Profit Margin
0.3195
Market Capitalization
219.8 B
Enterprise Value Revenue
5.4067
Revenue
41.9 B
There are currently one hundred twenty fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. All traders should validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 205.7 B in 2025. Enterprise Value is likely to gain to about 213.4 B in 2025

Abbott Laboratories Total Revenue

22.76 Billion

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 531 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets85.5 B81.4 B61.4 B
Slightly volatile
Short and Long Term Debt Total9.9 B15 B15.3 B
Slightly volatile
Other Current Liabilities8.3 B7.9 B6.3 B
Slightly volatile
Total Current Liabilities8.5 B14.2 B10.7 B
Slightly volatile
Total Stockholder Equity50 B47.7 B29.7 B
Slightly volatile
Property Plant And Equipment Net6.3 B10.7 B7.5 B
Slightly volatile
Net Debt6.1 B7.4 B8.4 B
Slightly volatile
Retained Earnings49.6 B47.3 B27.9 B
Slightly volatile
Cash8 B7.6 B7.2 B
Pretty Stable
Non Current Assets Total60.6 B57.8 B41.2 B
Slightly volatile
Non Currrent Assets Other17.3 B16.5 B7.4 B
Slightly volatile
Cash And Short Term Investments4.4 B8 B7.9 B
Very volatile
Net Receivables10 B9.5 B5.7 B
Slightly volatile
Common Stock Shares Outstanding1.3 B1.7 B1.7 B
Very volatile
Liabilities And Stockholders Equity85.5 B81.4 B61.4 B
Slightly volatile
Non Current Liabilities Total11.9 B19.4 B19.9 B
Slightly volatile
Inventory6.5 B6.2 B4.1 B
Slightly volatile
Other Current Assets2.2 B2.6 B2.6 B
Slightly volatile
Total Liabilities20.4 B33.5 B30.6 B
Slightly volatile
Property Plant And Equipment Gross23.9 B22.7 B11.3 B
Slightly volatile
Total Current Assets13.6 B23.7 B19.5 B
Pretty Stable
Short Term Debt2 B1.5 B1.8 B
Slightly volatile
Accounts Payable4.4 B4.2 B2.7 B
Slightly volatile
Current Deferred Revenue148.8 M156.6 M309.7 M
Slightly volatile
Common Stock Total Equity29.8 B28.4 B18.7 B
Slightly volatile
Short Term Investments333.4 M351 M929.6 M
Slightly volatile
Common Stock23.9 B25.2 B631.1 B
Slightly volatile
Intangible Assets9 B6.6 B10.1 B
Slightly volatile
Other Liabilities5.7 B7.6 B6.5 B
Slightly volatile
Other Assets5.9 B5.7 B3.4 B
Slightly volatile
Long Term Debt12.1 B12.6 B13.5 B
Slightly volatile
Property Plant Equipment7.7 B10.5 B7.6 B
Slightly volatile
Good Will15.9 B23.1 B17.2 B
Slightly volatile
Noncontrolling Interest In Consolidated Entity163.8 M251.8 M164.5 M
Slightly volatile
Retained Earnings Total Equity27.2 B40.5 B26.9 B
Slightly volatile
Long Term Debt Total15.8 B16.7 B14.7 B
Slightly volatile
Long Term Investments1.1 B886 M1.1 B
Very volatile
Non Current Liabilities Other4.2 B3.4 B5.1 B
Slightly volatile
Short and Long Term Debt1 B1.5 B844.9 M
Slightly volatile
Cash And Equivalents7.1 B8.9 B12.5 B
Slightly volatile
Net Invested Capital59.4 B61.8 B56.5 B
Slightly volatile
Net Working Capital9.5 B9.5 B9.8 B
Slightly volatile
Capital Stock26.8 B25.2 B24.1 B
Slightly volatile
Capital Lease Obligations990.2 M896 M824.1 M
Slightly volatile

Abbott Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.4 B3.2 B2.2 B
Slightly volatile
Selling General Administrative6.4 B11.7 B8.9 B
Slightly volatile
Total Revenue22.8 B42 B30.1 B
Slightly volatile
Gross Profit12.9 B23.2 B17.2 B
Slightly volatile
Other Operating Expenses18.7 B35.1 B25.4 B
Slightly volatile
Operating Income3.9 B6.8 B4.7 B
Slightly volatile
EBIT3.9 B7.6 B4.6 B
Slightly volatile
EBITDA11.4 B10.8 B7 B
Slightly volatile
Cost Of Revenue9.9 B18.7 B12.9 B
Slightly volatile
Total Operating Expenses8.8 B16.4 B12.4 B
Slightly volatile
Income Before Tax3.9 B7 B4.4 B
Slightly volatile
Net Income14.1 B13.4 B5 B
Slightly volatile
Research Development2.3 B2.8 B2.4 B
Very volatile
Net Income Applicable To Common Shares8.4 B8 B4.5 B
Slightly volatile
Minority Interest264.4 M251.8 M147.1 M
Slightly volatile
Selling And Marketing Expenses476.3 K569.2 K493.7 K
Pretty Stable
Net Income From Continuing Ops14.1 B13.4 B5.1 B
Slightly volatile
Non Recurring397 M331.2 M314.2 M
Very volatile
Discontinued Operations20.5 M21.6 M330.6 M
Slightly volatile
Interest Income279.9 M344 M187.5 M
Slightly volatile
Reconciled Depreciation2.3 B3.2 B2.9 B
Slightly volatile

Abbott Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow4 B6.4 B4.7 B
Slightly volatile
Begin Period Cash Flow3.9 B6.9 B6.7 B
Pretty Stable
Depreciation1.9 B3.2 B2.5 B
Slightly volatile
Dividends Paid4 B3.8 B2.4 B
Slightly volatile
Capital Expenditures1.3 B2.2 B1.5 B
Slightly volatile
Total Cash From Operating Activities5.3 B8.6 B6.2 B
Slightly volatile
Net Income14.1 B13.4 B4.8 B
Slightly volatile
End Period Cash Flow4.2 B7.6 B6.9 B
Pretty Stable
Stock Based Compensation373.2 M673 M431.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.94.66923.6349
Slightly volatile
Dividend Yield0.01860.01960.0257
Slightly volatile
PTB Ratio2.634.10943.6888
Slightly volatile
Days Sales Outstanding50.5482.614464.3593
Slightly volatile
Book Value Per Share29.0427.661317.8087
Slightly volatile
Free Cash Flow Yield0.03080.03240.052
Slightly volatile
Operating Cash Flow Per Share5.194.9423.8355
Slightly volatile
Stock Based Compensation To Revenue0.00840.0160.013
Slightly volatile
Capex To Depreciation1.070.68580.7159
Pretty Stable
PB Ratio2.634.10943.6888
Slightly volatile
EV To Sales5.094.84573.8976
Slightly volatile
Free Cash Flow Per Share3.853.66752.9016
Slightly volatile
ROIC0.170.18970.0963
Pretty Stable
Inventory Turnover3.963.023.4731
Slightly volatile
Net Income Per Share8.137.73922.9704
Slightly volatile
Days Of Inventory On Hand82.18121106
Slightly volatile
Payables Turnover7.264.45916.278
Slightly volatile
Sales General And Administrative To Revenue0.220.290.3096
Slightly volatile
Research And Ddevelopement To Revenue0.09690.06780.0795
Slightly volatile
Capex To Revenue0.07130.05260.0543
Pretty Stable
Cash Per Share4.834.60074.9704
Very volatile
POCF Ratio24.0322.887618.6275
Slightly volatile
Interest Coverage23.4112.209325.5019
Slightly volatile
Payout Ratio0.490.28620.7553
Very volatile
Capex To Operating Cash Flow0.350.25790.2851
Slightly volatile
PFCF Ratio32.3830.841226.0571
Slightly volatile
Days Payables Outstanding48.8681.854865.0669
Slightly volatile
Income Quality0.610.63862.1767
Pretty Stable
ROE0.260.28120.1609
Pretty Stable
EV To Operating Cash Flow24.9423.752919.9654
Slightly volatile
PE Ratio17.1114.615238.0165
Very volatile
Return On Tangible Assets0.170.25940.1309
Slightly volatile
EV To Free Cash Flow33.6132.007127.8952
Slightly volatile
Earnings Yield0.09260.06840.0536
Slightly volatile
Intangibles To Total Assets0.290.36550.4128
Slightly volatile
Net Debt To EBITDA0.770.68351.2399
Pretty Stable
Current Ratio1.241.6711.8831
Slightly volatile
Receivables Turnover6.444.41815.7386
Slightly volatile
Graham Number72.6969.230833.1803
Slightly volatile
Shareholders Equity Per Share28.927.524417.7101
Slightly volatile
Debt To Equity0.40.31510.5445
Pretty Stable
Capex Per Share0.651.27450.8908
Slightly volatile
Revenue Per Share25.4424.224818.7527
Slightly volatile
Interest Debt Per Share7.588.99699.5269
Pretty Stable
Debt To Assets0.180.18450.2488
Very volatile
Enterprise Value Over EBITDA19.718.762917.1264
Slightly volatile
Short Term Coverage Ratios3.765.70537.9815
Pretty Stable
Price Earnings Ratio17.1114.615238.0165
Very volatile
Operating Cycle133203171
Pretty Stable
Price Book Value Ratio2.634.10943.6888
Slightly volatile
Days Of Payables Outstanding48.8681.854865.0669
Slightly volatile
Dividend Payout Ratio0.490.28620.7553
Very volatile
Price To Operating Cash Flows Ratio24.0322.887618.6275
Slightly volatile
Price To Free Cash Flows Ratio32.3830.841226.0571
Slightly volatile
Pretax Profit Margin0.210.16720.1458
Slightly volatile
Ebt Per Ebit1.091.02750.9452
Pretty Stable
Operating Profit Margin0.210.16270.157
Pretty Stable
Company Equity Multiplier1.721.70812.093
Slightly volatile
Long Term Debt To Capitalization0.180.20940.2953
Very volatile
Total Debt To Capitalization0.260.23960.339
Pretty Stable
Return On Capital Employed0.09640.10150.1072
Slightly volatile
Debt Equity Ratio0.40.31510.5445
Pretty Stable
Ebit Per Revenue0.210.16270.157
Pretty Stable
Quick Ratio0.971.23351.5152
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.891.41621.6259
Pretty Stable
Net Income Per E B T2.011.9111.0102
Slightly volatile
Cash Ratio0.30.5380.6896
Very volatile
Cash Conversion Cycle122122111
Slightly volatile
Operating Cash Flow Sales Ratio0.230.2040.199
Slightly volatile
Days Of Inventory Outstanding82.18121106
Slightly volatile
Days Of Sales Outstanding50.5482.614464.3593
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.540.74210.7081
Pretty Stable
Cash Flow Coverage Ratios0.910.56970.5571
Pretty Stable
Price To Book Ratio2.634.10943.6888
Slightly volatile
Fixed Asset Turnover2.663.9363.8646
Very volatile
Capital Expenditure Coverage Ratio2.983.87773.9162
Very volatile
Price Cash Flow Ratio24.0322.887618.6275
Slightly volatile
Enterprise Value Multiple19.718.762917.1264
Slightly volatile
Debt Ratio0.180.18450.2488
Very volatile
Cash Flow To Debt Ratio0.910.56970.5571
Pretty Stable
Price Sales Ratio4.94.66923.6349
Slightly volatile
Return On Assets0.130.16460.0793
Pretty Stable
Asset Turnover0.840.51530.5575
Pretty Stable
Net Profit Margin0.170.31950.1387
Slightly volatile
Gross Profit Margin0.620.55410.5706
Very volatile
Price Fair Value2.634.10943.6888
Slightly volatile
Return On Equity0.260.28120.1609
Pretty Stable

Abbott Laboratories Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap205.7 B195.9 B131.6 B
Slightly volatile
Enterprise Value213.4 B203.3 B139.6 B
Slightly volatile

Abbott Fundamental Market Drivers

Forward Price Earnings24.6305
Cash And Short Term Investments8 B

Abbott Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue156.6 M148.8 M
Total Revenue42 B22.8 B
Cost Of Revenue18.7 B9.9 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.29  0.22 
Research And Ddevelopement To Revenue 0.07  0.10 
Capex To Revenue 0.05  0.07 
Revenue Per Share 24.22  25.44 
Ebit Per Revenue 0.16  0.21 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY